πŸ‡ΊπŸ‡Έ FDA
Patent

US 8877796

Spiro-oxindole MDM2 antagonists

granted A61KA61K31/407A61K31/454

Quick answer

US patent 8877796 (Spiro-oxindole MDM2 antagonists) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/407, A61K31/454, A61K31/496, A61K31/5377